Intended for healthcare professionals

Letters

Angiotensin receptor blockers and myocardial infarction

BMJ 2005; 330 doi: https://doi.org/10.1136/bmj.330.7502.1270 (Published 26 May 2005) Cite this as: BMJ 2005;330:1270

Direct comparative studies are needed

  1. Lionel H Opie, director (opie@capeheart.uct.ac.za)1
  1. 1 Hatter Institute, University of Cape Town, Medical School, Observatory, Cape Town, South Africa

    Editor—The editorial by Verma and Strauss does not accord with the BMJ's usual impartial evidence based approach.1 Evidence that angiotensin receptor blockers increase myocardial infarction is scant, and I remain puzzled about what exactly patients should be told—that the BMJ published an incorrect analysis?

    Regarding angiotensin receptor blockers and myocardial infarction in hypertension, the …

    View Full Text

    Log in

    Log in through your institution

    Subscribe

    * For online subscription